Zian Pan
Engineering · Purdue University West Lafayette
Publications
27
Citations
464
Est. group size
—
Recurring co-author estimate
Active years
7
Publishing since 2020
Zian Pan's work centers on designing nanoparticle-based materials for treating cancer and other diseases, including strategies that combine drug delivery, gene silencing, and imaging in a single nanoscale platform. Much of the research focuses on nanocomposites for cancer therapy (breast, colorectal), as well as applications in Alzheimer's disease, osteoporosis, and disk degeneration. A few recent items outside this core area touch on brain-machine interfaces, pose estimation algorithms, and physics topics, suggesting some breadth beyond the main nanomedicine focus.
Publications were minimal before 2020, then rose to a steady pace of about 4-8 papers per year between 2020 and 2024, indicating a growing and active output over the past five years, though with no recorded output in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Improving Animal Pose Estimation through Species Similarity Measures and Rigorous Label Definition
2026
- OXPHOS-targeted nanoparticles for boosting photodynamic therapy against hypoxia tumor
International Journal of Pharmaceutics · 2024
- Facile synthesis of EGCG modified Au nanoparticles and their inhibitory effects on amyloid protein aggregation
International Journal of Biological Macromolecules · 2024
- An antifouling electrochemical sensor integrating ‘‘3-in-1″ dual-targeted aptamer for the detection of the SARS-CoV-2 spike protein
Applied Surface Science · 2024
- Correction: Li et al. Fabrication of Poly Dopamine@poly (Lactic Acid-Co-Glycolic Acid) Nanohybrids for Cancer Therapy via a Triple Collaboration Strategy. Nanomaterials 2023, 13, 1447
Nanomaterials · 2024
- Brain machine interface for Parkison's disease
Theoretical and Natural Science · 2024
- Atomic-thick porous Pd nanosheets with antioxidant enzyme-like activities and photothermal properties for potential Alzheimer’s disease treatment
Nano Today · 2023
- Sequential-delivery nanocomplex for combined anti-angiogenesis and gene therapy against colorectal cancer
International Journal of Pharmaceutics · 2023
- Fabrication of Poly Dopamine@poly (Lactic Acid-Co-Glycolic Acid) Nanohybrids for Cancer Therapy via a Triple Collaboration Strategy
Nanomaterials · 2023
- Self-assembled nanocomposites of carboxymethyl β-dextran/protamine sulfate for enhanced chemotherapeutic drug sensitivity of triple-negative breast cancer by autophagy inhibition via a ternary collaborative strategy
International Journal of Biological Macromolecules · 2023
- Periostin-targeted SDSSD peptide decorated calcium phosphate nanocomposites incorporation with simvastatin for osteoporosis treatment
Nanotechnology · 2023
- Long-acting anti-colorectal cancer by nanocomplex co-regulating Bmi1 through miR-218 and siCCAT1
Journal of Drug Delivery Science and Technology · 2023
- Boosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca2+ overload and obatoclax-mediated autophagy inhibition as supported by a novel nano-modulator GO-Alg@CaP/CO
Journal of Nanobiotechnology · 2022
- Identification of inflammatory regulation roles of thalidomide/ruxolitinib in nucleus pulposus and construction of polyelectrolyte nanocomplexes-impregnated injectable hydrogels for synergistic intervertebral disk degeneration treatment
Nano Today · 2022
- The Solution to galaxy rotation curve problem——Dark matter and MOND
Journal of Physics Conference Series · 2022
- Biomaterials Science×3
- Advanced Materials×2
- Nano Today×2
- Journal of Nanobiotechnology×2
- International Journal of Pharmaceutics×2
- Yang Li
Engineering · The Ohio State University
- Hanh Thuy Nguyen
Engineering · Purdue University West Lafayette
- Jiangsheng Xu
Engineering · The Ohio State University
- Yifan Ma
Engineering · The Ohio State University
- Jessica C. Hsu
Engineering · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile